Search Completed | Title | Adding PEMF to Medications for Diabetic Peripheral Neuropathy
Original File Name Searched: jlms-11-20.pdf | Google It | Yahoo | Bing

Page | 003 Shanb et al had 3 pre-stored programs with different intensity and treatment times. 29 2- The Laser Scanner device (ASA Com. srl, Arcugnano, Italy): It emits a mixed light of both the He-Ne continuous wavelength of 850 nanometers (nm) and the pulsed infrared laser with the wavelength 905 nm. The device had maximum power of 10 watt (W). The output density of the device is calibrated at each applied program and selected frequency.4 Procedures Assessment Procedure The following measures were employed for all recruited patients by a blinded investigator. a. Fasting Blood Glucose A venous fasting blood sample was drawn from the anti-cubital vein to detect the blood glucose level (pre- intervention, after 6 weeks and at the end of treatment) for all patients.28 b. Electrophysiological Test MCV of the peroneal nerve and sensory conduction velocity (SCV) of the sural nerve in addition its amplitudes were measured by a neuro-consultant.22,28 The patients with conduction velocity from 33-48 meter/second were Table 1. Demographic Data of Recruited Patients Variables BMI, kg/ m2 Duration of incidence of diabetes (y) Pre-FBG, mg/dL Post-FBG, mg/dL Insulin, No. (%) Magnetic Group Mean ± SD 27.32 ± 1.75 16.31 ±7.61 142.38 ±6.8 136.5 ±5.46 5 (19.2) Laser Group Mean ± SD 28.17 ± 1.97 18.8 ±7.58 140.68 ±6.77 136.2 ±5.17 4 (16) Drug Group Mean ± SD 27.79 ± 1.46 13.65 ± 6.71 141.5 ± 7.01 136.6 ±5.19 4 (20) F Value 1.493 2.726 0.395 0.062 P Value 0.232 0.073 0.675 0.940 Figure 1. The Flow Diagram of Patients› Recruitment. Age (y) 60.31 ± 9.82 58.88 ± 12.15 54.05 ±10.69 1.971 0.147 Sex, No. (%) 0.209 0.812 Males 18 (69.3) 16 (64) 12 -- (60) Females 8 (30.7) 9 (36) 8 -- (40) Duration of beginning of diabetic neuropathy (y) 4.11 ±2.55 5.0 ±2.71 3.25 ± 2.07 2.767 0.070 in-FBG, mg/dL 136.38 ±5.32 136.08 ±4.99 135.85 ±5.16 0.044 0.957 Oral drugs, No. (%) 21 (80.8) 21 (84) 16 (80) 0.142 0.931 BMI: body mass index; FBG, fasting blood glucose; in-FBG mg/dL: fasting blood glucose after 6 weeks. 22 Journal of Lasers in Medical Sciences Volume 11, Number 1, Winter 2020
|